Trial Profile
Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in Pediatric Intensive Care Unit. A Multicenter, Double-blind, Randomized Controlled Trial.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2022
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Substance withdrawal syndrome
- Focus Therapeutic Use
- Acronyms TIP-15-01
- 02 Nov 2021 This trial has been discontinued due to futility reasons, according to ClinicalTrials.gov record.
- 02 Sep 2021 Status changed from recruiting to discontinued.
- 11 Dec 2019 Trial design assessing efficacy of dexmedetomidine in reducing the occurrence of WS during analgosedation weaning and safety, published in the Trials.